Institution:
Jacobs School of Medicine and Biomedical Sciences, the University at BuffaloResearchers:
Michael D. Sitrin, MD, professor of medicine at University at Buffalo Jacobs School of Medicine and Biomedical Sciences, co-directed the seven-site clinical trial of the SmartPill
Impact:
The diagnosis and treatment of gastrointestinal (GI) disorders have been greatly improved by the SmartPill, an ingestible diagnostic sensing capsule that travels every inch of the 30-foot-long human GI tract while making and recording key measurements.
Timeline:
In 2006, the SmartPill received approval by the Food and Drug Administration. Three years later, it was highlighted in a Forbes magazine story on cutting-edge life-saving technologies.